Fri, Aug 2, 12:19 PM (230 days ago)
Exagen Inc. has appointed Jeffrey Black as Chief Financial Officer (CFO) effective September 1, 2024. Black, currently CFO at Standard BioTools Inc., has a robust background including roles at Apollo Endosurgery, Alphatec Holdings, Applied Proteomics, AltheaDx, and Verenium Corporation. His compensation package includes a $460,000 annual base salary, a $125,000 signing bonus, and an annual performance bonus up to 50% of his base salary. He will also receive 225,000 restricted stock units vesting over four years. Concurrently, John Aballi has been named Interim CFO, replacing Kamal Adawi. Adawi will receive severance benefits per company policy. The company announced these changes via a press release on August 1, 2024.